Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs, Ahmet Zehir, Sean M. Devlin, et al.
Cell stem cell (2017) Vol. 21, Iss. 3, pp. 374-382.e4
Open Access | Times Cited: 705

Showing 26-50 of 705 citing articles:

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Detlef Haase, Kristen E. Stevenson, Donna Neuberg, et al.
Leukemia (2019) Vol. 33, Iss. 7, pp. 1747-1758
Open Access | Times Cited: 221
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
Yuxuan Wang, Lu Li, Christopher Douville, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 433
Open Access | Times Cited: 205
Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis
Alexander Heyde, David Rohde, Cameron S. McAlpine, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1348-1361.e22
Open Access | Times Cited: 205
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
Josephine Kahn, Peter G. Miller, Alexander J. Silver, et al.
Blood (2018) Vol. 132, Iss. 11, pp. 1095-1105
Open Access | Times Cited: 189
Clonal Hematopoiesis
Peter Libby, Robert Sidlow, Amy Lin, et al.
Journal of the American College of Cardiology (2019) Vol. 74, Iss. 4, pp. 567-577
Open Access | Times Cited: 183
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential
Terrence N. Wong, Christopher A. Miller, Matthew Jotte, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 179
Clinical consequences of clonal hematopoiesis of indeterminate potential
David P. Steensma
Hematology (2018) Vol. 2018, Iss. 1, pp. 264-269
Open Access | Times Cited: 179
Clinical consequences of clonal hematopoiesis of indeterminate potential
David P. Steensma
Blood Advances (2018) Vol. 2, Iss. 22, pp. 3404-3410
Open Access | Times Cited: 177
Precision medicine in non-small cell lung cancer: Current applications and future directions
Soo‐Ryum Yang, Anne M. Schultheis, Helena A. Yu, et al.
Seminars in Cancer Biology (2020) Vol. 84, pp. 184-198
Closed Access | Times Cited: 173
Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
Travis A. Clark, Jon Chung, Mark Kennedy, et al.
Journal of Molecular Diagnostics (2018) Vol. 20, Iss. 5, pp. 686-702
Open Access | Times Cited: 172
Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
Christopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, et al.
Leukemia (2018) Vol. 32, Iss. 9, pp. 1908-1919
Closed Access | Times Cited: 168
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan Ptashkin, Diana Mandelker, Catherine C. Coombs, et al.
JAMA Oncology (2018) Vol. 4, Iss. 11, pp. 1589-1589
Open Access | Times Cited: 168
Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 161
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
R Chin, Kevin Chen, Abul Usmani, et al.
Molecular Diagnosis & Therapy (2019) Vol. 23, Iss. 3, pp. 311-331
Open Access | Times Cited: 153
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Michael L. Cheng, Eirini Pectasides, Glenn J. Hanna, et al.
CA A Cancer Journal for Clinicians (2020) Vol. 71, Iss. 2, pp. 176-190
Open Access | Times Cited: 150
Clonal hematopoiesis and non-hematologic disorders
Siddhartha Jaiswal
Blood (2020)
Open Access | Times Cited: 149
Clinical cancer genomic profiling
Debyani Chakravarty, David B. Solit
Nature Reviews Genetics (2021) Vol. 22, Iss. 8, pp. 483-501
Closed Access | Times Cited: 140
Cell-free DNA analysis in current cancer clinical trials: a review
Mireya Cisneros-Villanueva, Lizbett Hidalgo Pérez, M. Rios-Romero, et al.
British Journal of Cancer (2022) Vol. 126, Iss. 3, pp. 391-400
Open Access | Times Cited: 139
Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis
Ryunosuke Saiki, Yukihide Momozawa, Yasuhito Nannya, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1239-1249
Open Access | Times Cited: 114
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Justin Jee, Emily S. Lebow, Randy Yeh, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2353-2363
Open Access | Times Cited: 111
Current and Future Clinical Applications of ctDNA in Immuno-Oncology
Julia-Christina Stadler, Yassine Belloum, Benjamin Deitert, et al.
Cancer Research (2021) Vol. 82, Iss. 3, pp. 349-358
Open Access | Times Cited: 108
Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation
Anna S. Nam, Neville Dusaj, Franco Izzo, et al.
Nature Genetics (2022) Vol. 54, Iss. 10, pp. 1514-1526
Open Access | Times Cited: 96
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms
Adam S. Sperling, Veronica Guerra, James A. Kennedy, et al.
Blood (2022) Vol. 140, Iss. 16, pp. 1753-1763
Open Access | Times Cited: 93
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
J.E. Berchuck, Francesco Facchinetti, Daniel DiToro, et al.
Annals of Oncology (2022) Vol. 33, Iss. 12, pp. 1269-1283
Open Access | Times Cited: 86
Cardiovascular disease and cancer: shared risk factors and mechanisms
Nicholas S. Wilcox, Uri Amit, Jacob B. Reibel, et al.
Nature Reviews Cardiology (2024) Vol. 21, Iss. 9, pp. 617-631
Closed Access | Times Cited: 80

Scroll to top